Alyssum Therapeutics
Developer of supramolecular therapeutics designed for cancer patients. The company offers treatments and antibody drugs to treat lung, testicular, colorectal, and childhood cancers, its therapeutics u...
Valuation
$0
Share Price
N/A
Total Raised
$32.7M
Last Round
N/A